Stephen A. Harrison, MD
Brooke Army Medical Center
16
15
14
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+11 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (16)
Showing 10 of 16 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Nezam Afdhal, MD
Beth Israel Deaconess Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Victor Navarro, MD
Thomas Jefferson University
Shared therapeutic areas:
Worked with same sponsors:
K. Rajender Reddy, MD
University of Pennsylvania
Shared therapeutic areas:
Worked with same sponsors:
Michael Fried, MD
University of North Carolina, Chapel Hill
Shared therapeutic areas:
Worked with same sponsors:
Naga Chalasani, MD
Indiana University
Shared therapeutic areas:
Worked with same sponsors:
Marc G Ghany, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Worked with same sponsors:
Ram Subramanian, MD
Emory University Hospital (Transplant Center Clinical Research)
Shared therapeutic areas:
Worked with same sponsors:
Ahmed Aijaz, MD
Stanford University
Shared therapeutic areas:
Worked with same sponsors:
Joseph Lim, MD
Yale University Digestive Diseases
Shared therapeutic areas:
Worked with same sponsors:
Norman Gitlin, MD
Atlanta Gastroenterology Associates
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (16)
Showing 16 of 16 trials
ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)
A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis
Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis
Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH)
An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis
Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)
Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus
Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With CHC
Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin
Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C
Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects
The Effects of Mogroside Sweetener on Viral Load in TreatmenT Naive Genotype 1 (GT 1) Subjects CHC
Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy
Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis
All 16 trials loaded